Pooja is an engagement manager based out of Lifescience Dynamics’ Toronto office. She has over 9 years of experience in the pharmaceutical consulting industry. Pooja brings expertise in competitive intelligence, opportunity assessment, market access, and pricing and disease area strategy projects in immunology and other therapy areas.
During the early part of her career, she also worked in analytical R&D at a leading ophthalmic manufacturing firm. Pooja holds an MS(Pharm) in Medicinal Chemistry from National Institute of Pharmaceutical Education and Research (NIPER), Mohali, India, and a bachelor’s in pharmaceutical science from Panjab University, Chandigarh, India.
Long-acting HIV therapies promise greater convenience, but fewer doses alone may not solve adherence or access challenges. Lloyd Bibby and Pooja Goyal, MS(Pharm), discuss patient choice, weekly oral and injectable therapies, health system capacity, equitable access, and the real-world measures that will define success.